292 related articles for article (PubMed ID: 24012704)
1. Formulation and in vitro evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric mixed micelles for glioblastoma multiforme.
Saxena V; Hussain MD
Colloids Surf B Biointerfaces; 2013 Dec; 112():350-5. PubMed ID: 24012704
[TBL] [Abstract][Full Text] [Related]
2. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
4. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.
Onyüksel H; Mohanty PS; Rubinstein I
Int J Pharm; 2009 Jan; 365(1-2):157-61. PubMed ID: 18793708
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization.
Wei Z; Hao J; Yuan S; Li Y; Juan W; Sha X; Fang X
Int J Pharm; 2009 Jul; 376(1-2):176-85. PubMed ID: 19409463
[TBL] [Abstract][Full Text] [Related]
6. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats.
Xiong MP; Yáñez JA; Kwon GS; Davies NM; Forrest ML
J Pharm Sci; 2009 Apr; 98(4):1577-86. PubMed ID: 18752263
[TBL] [Abstract][Full Text] [Related]
7. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.
Forrest ML; Zhao A; Won CY; Malick AW; Kwon GS
J Control Release; 2006 Nov; 116(2):139-49. PubMed ID: 16926059
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles.
Pradhan R; Poudel BK; Choi JY; Choi IS; Shin BS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015; 38(5):734-41. PubMed ID: 24824337
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation of the HSP-90 Chaperone Inhibitor 17-AAG in Stable Liposome Allow Increasing the Therapeutic Index as Assessed,
Petersen ALOA; Campos TA; Dantas DADS; Rebouças JS; da Silva JC; de Menezes JPB; Formiga FR; de Melo JV; Machado G; Veras PST
Front Cell Infect Microbiol; 2018; 8():303. PubMed ID: 30214897
[TBL] [Abstract][Full Text] [Related]
10. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis.
Katragadda U; Fan W; Wang Y; Teng Q; Tan C
PLoS One; 2013; 8(3):e58619. PubMed ID: 23505544
[TBL] [Abstract][Full Text] [Related]
11. Multi-drug delivery to tumor cells via micellar nanocarriers.
Katragadda U; Teng Q; Rayaprolu BM; Chandran T; Tan C
Int J Pharm; 2011 Oct; 419(1-2):281-6. PubMed ID: 21820041
[TBL] [Abstract][Full Text] [Related]
12. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
Shin DH; Kwon GS
Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
[TBL] [Abstract][Full Text] [Related]
13. Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.
Desale SS; Raja SM; Kim JO; Mohapatra B; Soni KS; Luan H; Williams SH; Bielecki TA; Feng D; Storck M; Band V; Cohen SM; Band H; Bronich TK
J Control Release; 2015 Jun; 208():59-66. PubMed ID: 25660204
[TBL] [Abstract][Full Text] [Related]
14. Development and Evaluation of a Novel Drug Delivery: Pluronics/SDS Mixed Micelle Loaded With Myricetin In Vitro and In Vivo.
Wang G; Wang JJ; Li F; To SS
J Pharm Sci; 2016 Apr; 105(4):1535-43. PubMed ID: 26947760
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
[TBL] [Abstract][Full Text] [Related]
16. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer.
Ghalhar MG; Akbarzadeh A; Rahmati M; Mellatyar H; Dariushnejad H; Zarghami N; Barkhordari A
Asian Pac J Cancer Prev; 2014; 15(17):7113-8. PubMed ID: 25227799
[TBL] [Abstract][Full Text] [Related]
18. HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
Belkacemi L; Hebb MO
Anticancer Res; 2014 Sep; 34(9):4915-27. PubMed ID: 25202074
[TBL] [Abstract][Full Text] [Related]
19. Nevirapine loaded Poloxamer 407/Pluronic P123 mixed micelles: Optimization of formulation and in vitro evaluation.
Jindal N; Mehta SK
Colloids Surf B Biointerfaces; 2015 May; 129():100-6. PubMed ID: 25839908
[TBL] [Abstract][Full Text] [Related]
20. SNX-25a, a novel Hsp90 inhibitor, inhibited human cancer growth more potently than 17-AAG.
Wang S; Wang X; Du Z; Liu Y; Huang D; Zheng K; Liu K; Zhang Y; Zhong X; Wang Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):73-80. PubMed ID: 24879994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]